HOMOEOPATHIC MANAGEMENT OF PRIMARY DYSMENORRHOEA WITH JAONESIA ASOCA: A CASE REPORT USING THE WALIDD SCORE AND REPERTORIAL ANALYSIS

Dysmenorrhea is a common gynaecological condition characterized by painful menstruation, usually presenting with lower abdominal cramps and may be associated with backache, nausea, headache, fatigue, and other systemic symptoms. It can adversely affect daily activities, academic performance, work, and overall quality of life.[1] A 23-year-old female presented with complaints of primary dysmenorrhea associated with premenstrual syndrome (PMS). The patient reported significant menstrual pain that adversely affected her daily activities and overall well-being. Considering the severity of her symptoms, a structured clinical assessment was undertaken to evaluate the intensity of dysmenorrhea and associated premenstrual symptoms. The patient's clinical status was assessed using validated outcome measures before the initiation of treatment and after three months of follow-up. Joanesia Ashoka tincture was administered as the intervention under observation. Serial follow-up assessments were conducted to document changes in symptom severity and evaluate the clinical response over the observation period. At the end of the three-month follow-up, the patient's dysmenorrhea severity improved from the severe category to the moderate category, indicating a reduction in the reported intensity of menstrual pain. The pre- and post-treatment assessments provided a structured means of documenting the observed clinical change. The associated PMS symptoms were also considered as part of the overall clinical evaluation. This case highlights the potential clinical relevance of further investigating Joanesia Ashoka in patients presenting with primary dysmenorrhea and associated PMS. However, as this report describes a single patient, the observed improvement cannot establish a causal relationship between the intervention and the outcome. Further well-designed clinical studies with adequate sample sizes, appropriate comparison groups, standardized outcome measures, and longer follow-up periods are required to evaluate the efficacy and safety of the preparation.